1. Long DM, BenDebba M, Torgerson WS, Boyd RJ, Dawson EG, Watts C, et al. Persistent back pain and sciatica in the United States: patient characteristics. J Spinal Disord 1996;9:40-58.
2. Roberts LJ, Morrow JD. In: Hardman JG, Limbird LE, editor. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. The pharmacological basis of therapeutics 2001;10th ed. New York: McGraw-Hill. 687-732.
3. Savage R. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly? Drugs Aging 2005;22:185-200.
4. Nielsen OH, Ainsworth M, Csillag C, Rask-Madsen J. Systematic review: coxibs, nonsteroidal anti-inflammatory drugs or no cyclooxygenase inhibitors in gastroenterological high-risk patients? Aliment Pharmacol Ther 2006;23:27-33.
5. Preston MR, Walter MF, McNulty HP, Lockwood SF, Byun J, Jacob RF, et al. Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity. J Cardiovasc Pharmacol 2006;47:Suppl 1. S7-S14.
6. Walt RP. Misoprostol for the treatment of peptic ulcer and antiinflammatory- drug-induced gastroduodenal ulceration. N Engl J Med 1992;327:1575-1580.
7. Kuffner EK, Dart RC, Bogdan GM, Hill RE, Casper E, Darton L. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double blind, placebo-controlled trial. Arch Intern Med 2001;161:2247-2252.
8. Malonne H, Coffiner M, Fontaine D, Sonet B, Sereno A, Vanderbist F, et al. Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. J Clin Pharm Ther 2005;30:113-120.
9. Raffa R. Pharmacologic aspects of successful long-term analgesia. Clin Rheumatol 2006;25:Suppl 1. S9-S15.
10. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N. Analgesic efficacy and safty of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic lowback pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol 2004;31:2454-2463.
11. Langford RM. Pain management today-what have we learned? Clin Rheumatol 2006;25:Suppl 1. S2-S8.
12. Jones D, Story DA. Serotonin syndrome and the anesthetist. Anaesth Intensive Care 2005;33:181-187.
13. Ballantyne JC, Mao J. Opioid therapy for Chronic Pain. N Engl J Med 2003;349:1943-1953.
14. Mahowald ML, Singh JA, Majeski P. Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum 2005;52:6-10.
15. Furian AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589-1594.
16. Eisenberg E, McNicol ED, Carr DB. Efficacy of Systemic review of randomized controlled trials. Eur J Pain 2006;Epub ahead of print.
17. Mystakidou K, Parpa E, Tsilika E, Marvromati A, Smyrniotis V, Vlahos L, et al. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J Pain 2003;4:298-306.
18. Kerns JW, White A, Nashelsky J, Sherman S. Does psychiatric treatment help patients with intractable chronic pain? J Fam Pract 2006;55:235-236.
19. Staiger TO, Gaster B, Sullivan MD, Deyo RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 2003;28:2540-2545.
20. Baron R, Binder A. How neuropathic is sciatica? The mixed pain concept Orthopade 2004;33:568-567.
21. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 2005;71:483-490.
22. Jackson JL, Browning R. Impact of national low back pain guidlines on clinical practice. South Med J 2005;98:139-143.
23. Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther 2004;26:1355-1367.
24. Beebe FA, Barkin RL, Barkin S. A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther 2005;12:151-171.